Drug – bio-affecting and body treating compositions – Solid synthetic organic polymer as designated organic active... – Monomer contains oxygen
Patent
1994-03-31
1998-03-24
Webman, Edward J.
Drug, bio-affecting and body treating compositions
Solid synthetic organic polymer as designated organic active...
Monomer contains oxygen
424 7808, 424 7817, 424 165, 424 9322, 424 9323, 530815, 530816, 525406, A61K 3177, A61K 4900, A61K 5100, C08G 6548
Patent
active
057309680
ABSTRACT:
A composition suitable for use in diagnostic imaging or as a cell killing agent comprising a chelating residue linked via an amide linkage to a poly(alkylene oxide) moiety, said composition having a molecular weight of at least 4,500; ##STR1## wherein: Z is a chelating residue;
REFERENCES:
patent: 3859337 (1975-01-01), Herz et al.
patent: 4916246 (1990-04-01), Felder et al.
patent: 5137711 (1992-08-01), Weber et al.
patent: 5283339 (1994-02-01), Arnold
Pharmaceuticals In Medical Imaging, Dennis P. Swanson, et al., 1990, pp. 645 to 681.
Butterfield Dennis E.
Fujii Dennis K.
Ladd David L.
Snow Robert A.
Tan Julia S.
Sterling Winthrop Inc.
Webman Edward J.
LandOfFree
Segmented chelating polymers as imaging and therapeutic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Segmented chelating polymers as imaging and therapeutic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Segmented chelating polymers as imaging and therapeutic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2286669